SCHEMBL3708575

SCHEMBL3708575

CCOc1cc(CCO)ccc1Br

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 1/20 0.46
S1PR3 Q99500 1/20 0.46
CALM1 P0DP23 3/20 0.43
SLC6A4 P31645 1/20 0.43
LMNA P02545 2/20 0.41
KMT2A Q03164 2/20 0.41
NPSR1 Q6W5P4 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.40
ALDH1A1 P00352 2/20 0.40
TSHR P16473 1/20 0.40
HSD17B10 Q99714 1/20 0.40
CYP4F2 P78329 1/20 0.40
CYP4A11 Q02928 1/20 0.40
KDM4E B2RXH2 1/20 0.40
ALOX5 P09917 1/20 0.40
GAA P10253 1/20 0.40
MAPT P10636 1/20 0.40
BACE1 P56817 1/20 0.40
HTT P42858 1/20 0.39
MEN1 O00255 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2406614 0.86 HTT (0.47) S1PR1S1PR3SLC6A4LMNAKMT2A
SCHEMBL9026143 0.84 S1PR1 (0.56) S1PR1S1PR3CALM1LMNAKMT2A
SCHEMBL8715027 0.82 TAAR1 (0.47) LMNAALDH1A1TSHRKDM4EALOX5
SCHEMBL31236986 0.82 TAAR1 (0.47) LMNAALDH1A1TSHRKDM4EALOX5
SCHEMBL6809980 0.81 ALDH1A1 (0.55) CALM1LMNAKMT2AALDH1A1TSHR
SCHEMBL28620316 0.80 LMNA (0.41) CALM1SLC6A4LMNAKMT2ANPSR1
SCHEMBL5873476 0.79 CALM1 (0.67) S1PR1S1PR3CALM1TSHRKDM4E
SCHEMBL2408767 0.79 LMNA (0.41) CALM1SLC6A4LMNAKMT2ANPSR1
SCHEMBL11022505 0.77 KDM4E (0.55) S1PR1S1PR3CALM1LMNAKMT2A
SCHEMBL12132523 0.77 S1PR1 (0.47) S1PR1S1PR3CALM1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2212317-A1 4,4-DISUBSTITUTED PIPERIDINES Novartis AG (CH) 2010-08-04 EP disclosed
WO-2009053452-A1 4,4-DISUBSTITUTED PIPERIDINES NOVARTIS AG (CH) 2009-04-30 WO disclosed